Condition : Arthritis, Rheumatoid Interventions : Drug: PRTX-100 at 1.5 mcg/kg; Drug: PRTX-100 at 3.0 mcg/kg; Drug: PRTX-100 at 6.0 mcg/kg; Drug: PRTX-100 at 12.0 mcg/kg; Drug: PRTX-100 at 240 mcg; Dr...

This is a phase 1, randomized, double-blind, placebo-controlled, multiple ascending dose study in healthy volunteers, multiple dose study in patients with rheumatoid arthritis and multiple dose study...

Condition : Osteoarthritis of the Knee Interventions : Drug: Imotun capsule; Drug: Imotun capsule placebo Sponsors : Chong Kun Dang Pharmaceutical; Chong Kun Dang Pharmaceutical Recruiting - verified...

Condition : Rheumatoid Arthritis Intervention : Sponsors : Hoffmann-La Roche; Hoffmann-La Roche Recruiting - verified September 2013

Condition : Rheumatoid Arthritis Intervention : Sponsor : Hoffmann-La Roche Active, not recruiting - verified February 2014

Condition : Rheumatoid Arthritis Intervention : Sponsor : Hoffmann-La Roche Active, not recruiting - verified November 2013

Condition : Osteoarthritis of the Knee Intervention : Device: KineSpring Knee Implant System (KineSpring System) Sponsor : Moximed Enrolling by invitation - verified February 2014

Condition : Osteoarthritis of the Knee Intervention : Device: KineSpring Knee Implant System (KineSpring System) Sponsors : Moximed; Moximed Enrolling by invitation - verified September 2013

Condition : Osteoarthritis Interventions : Other: Neutral insole with subtalar strapping (sham); Other: Lateral wedge insole with subtalar strapping Sponsors : University of Sao Paulo General Hospital...

Condition : Juvenile Idiopathic Arthritis Interventions : Drug: tocilizumab [RoActemra/Actemra]; Drug: tocilizumab [RoActemra/Actemra] Sponsor : Hoffmann-La Roche Recruiting - verified February 2014